Dr. Adib's appointment, with his vast oncology drug developm...
Dr. Adib's appointment, with his vast oncology drug development experience, is viewed as a crucial step to speed up FibroGen's oncology pipeline and deliver innovative cancer treatments. His leadership is anticipated to aid the company's ongoing and future clinical development activities.
Press Release: FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment